VLA15 for Lyme Neuroborreliosis
This trial is testing the safety and effectiveness of two different schedules of vaccinations for Lyme disease. The study will last a maximum of 19 months for participants, who will be given either 3 or 2 vaccinations. 600 people aged 5-65 years will be enrolled.
- Lyme Neuroborreliosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2020 Phase 2 trial • 572 Patients • NCT03769194
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many research centers are conducting this trial?
"The primary clinical trial site is Stamford Therapeutics Consortium in Stamford, Connecticut. Other locations where this study is running include Square-1 Clinical Research, Inc. - AHN Health and Wellness Pavilion in Erie, Rhode Island; Velocity Clinical Research - Providence in Warwick, New Jersey; as well as 14 other centres."
What is the known safety profile of VLA15?
"The safety of VLA15 has been tentatively established in Phase 2 clinical trials. However, more data is needed to confirm its efficacy."
If I meet the qualifications, may I join this experiment?
"This clinical trial is enrolling 625 participants with lyme polyradiculitis aged 5 and 65. Most notable, candidates must meet the following criteria: Parent(s)/legal representative(s) and subject understand the study and its procedures, agree to its provisions, Booster Phase: until Month 23 (i.e. 5 months after booster dose), Subject is aged 5 to 65 years at the day of screening (Visit 0), Subject is of good general health, Subject is willing and able to comply with scheduled visits, treatment plan, and other study procedures, Subject is available for the duration of the study and can be contacted"
Can patients sign up for this trial right now?
"According to the latest update on clinicaltrials.gov, this particular trial is not looking for new patients at this time. The study was originally posted on March 15th 2021 but has not been updated since July 26th of the same year. Although this may be the case, there are 8 other trials that are currently recruiting patients."
Can elderly patients participate in this scientific experiment?
"According to the rules that determine who can participate in this research, the youngest age an individual can be is 5 and the oldest is 65."